Delayed federal health tracking and limited testing are making it harder to trace the source of an ongoing outbreak of a parasitic disease.
The big picture: While cases of cyclosporiasis normally climb in the summer months, this year's outbreak has spread rapidly and sickened thousands of people across at least 31 states.
The life sciences community is splintering over how the U.S. should respond to China's rapid biotech advances — specifically over whether more protectionist policies are needed to preserve American dominance.
Why it matters: The debate features a complicated web of national security concerns, high-stakes financial interests and, ultimately, the question of what is best for patients.
